Tumour Infiltrating Lymphocyte -Adoptive Cell Therapy: The Emerging Importance of Clonal Neoantigen Targets for Next-Generation Products in Non-Small Cell Lung Cancer

Immuno-Oncology Technology
doi 10.1016/j.iotech.2019.09.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Predictive Significance of T Cell Subset Changes During Ex�vivo Generation of Adoptive Cellular Therapy Products for the Treatment of Advanced Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Toward Precision Medicine With Next-Generation EGFR Inhibitors in Non-Small-Cell Lung Cancer

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2014English

Advances in Immune Therapy for Non Small Cell Lung Cancer

Medical Diagnosis
2016English

New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Maintenance Therapy for Advanced Non-Small Cell Lung Cancer: Current Status, Controversies, and Emerging Consensus

Clinical Cancer Research
Cancer ResearchOncology
2010English

Emerging Roles of Nrf2 Signal in Non-Small Cell Lung Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Tumor Infiltrating Lymphocyte Therapy for Ovarian Cancer and Renal Cell Carcinoma

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2015English

Mutational Profile of Non-Small Cell Lung Cancer by Targeted Next-Generation Sequencing in the Mexican Population

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Interleukin-10-Regulated Tumour Tolerance in Non-Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy